Fei Tang

7PUBLICATIONS
13CO-AUTHORS
Pharmaceutical delivery technologiesHaematological tumoursClinical pharmacology and therapeuticsToxicology (incl. clinical toxicology)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 17, 2026
Perspective on Pharmacokinetic Comparability for Biologics Development.

|Mar 08, 2026
Population Pharmacokinetic Analysis of Vixarelimab in Healthy Volunteers and Patients With Chronic Pruritic Conditions.

Fei Tang, Steve Dang, Audrey Arjomandi

|Feb 11, 2025
Indication-Specific Dosing and Dose-Evaluation Strategies in New Indications for Non-Oncology Monoclonal Antibodies.

Sherouk M Tawfik, Fei Tang

|Nov 22, 2024
Pharmacokinetic Modeling and Model-Based Hypothesis Generation for Dose Optimization of Clonidine in Neonates With Neonatal Opioid Withdrawal Syndrome.

Fei Tang, Chee M Ng, Jamie Horn

|Jun 23, 2023
First-in-human phase 1 trial evaluating safety, pharmacokinetics, and pharmacodynamics of NLRP3 inflammasome inhibitor, GDC-2394, in healthy volunteers.

Fei Tang, Rebecca Kunder, Tom Chu

|Oct 24, 2022
Population Pharmacokinetics of Tenecteplase in Patients With Acute Myocardial Infarction and Application to Patients With Acute Ischemic Stroke.

Fei Tang, Jurgen Langenhorst, Steve Dang

Pageof 2

Frequent Collaborators

1 joint publications

Ryan Owen

1 joint publications

Liuxi Chen

1 joint publications

David Place

1 joint publications

Chee M Ng